Christopher Dominic Buckley

Christopher Dominic Buckley

Top Cited Scholar 2026
Auto-generated profile, based on publicly available information

Christopher Dominic Buckley

Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2019 in Nature
Verified
Journal Article
Closed access
PDF file
ACAdam P. Croft
Adam P. Croft
JCJoana Campos
Joana Campos
KJKathrin Jansen
Kathrin Jansen
JTJason D. Turner
Jason D. Turner
JMJennifer Marshall
Jennifer Marshall
CBChristopher D. Buckley
Christopher D. Buckley

29 June 2020 in Nature Medicine
Verified
Journal Article
Open access
PDF file
Stefano AliverniniStefano Alivernini
Stefano Alivernini
LMLucy MacDonald
Lucy MacDonald
AEAziza Elmesmari
Aziza Elmesmari
SFSamuel Finlay
Samuel Finlay
BTBarbara Tolusso
Barbara Tolusso
MKMariola Kurowska-Stolarska
Mariola Kurowska-Stolarska
Immune-regulatory mechanisms of drug-free remission in rheumatoid arthritis (RA) are unknown. We hypothesized that synovial tissue macrophages (STM), which persist in remission, contribute to joint homeostasis. We used single-cell transcriptomics to profile 32,000 STMs and identified phenotypic changes in patients with early/active RA, treatment-refractory/active RA and RA in sustained remission. Each clinical state was characterized by different frequencies of nine discrete phenotypic clusters within four distinct STM subpopulations with diverse homeostatic, regulatory and inflammatory functions. This cellular atlas, combined with deep-phenotypic, spatial and functional analyses of synovial biopsy fluorescent activated cell sorted STMs, revealed two STM subpopulations (MerTKposTREM2high and MerTKposLYVE1pos) with unique remission transcriptomic signatures enriched in negative regulators of inflammation. These STMs were potent producers of inflammation-resolving lipid mediators and induced the repair response of synovial fibroblasts in vitro. A low proportion of MerTKpos STMs in remission was associated with increased risk of disease flare after treatment cessation. Therapeutic modulation of MerTKpos STM subpopulations could therefore be a potential treatment strategy for RA.

28 April 2021 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
SDSarah Davidson
Sarah Davidson
MCMark Coles
Mark Coles
TTTom Thomas
Tom Thomas
GKGeorge Kollias
George Kollias
BLBurkhard Ludewig
Burkhard Ludewig
CBChristopher D. Buckley
Christopher D. Buckley

23 February 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
FMFumitaka Mizoguchi
Fumitaka Mizoguchi
KSKamil Slowikowski
Kamil Slowikowski
KWKevin Wei
Kevin Wei
JMJennifer L. Marshall
Jennifer L. Marshall
DRDeepak A. Rao
Deepak A. Rao
MBMichael B. Brenner
Michael B. Brenner
Fibroblasts regulate tissue homeostasis, coordinate inflammatory responses, and mediate tissue damage. In rheumatoid arthritis (RA), synovial fibroblasts maintain chronic inflammation which leads to joint destruction. Little is known about fibroblast heterogeneity or if aberrations in fibroblast subsets relate to pathology. Here, we show functional and transcriptional differences between fibroblast subsets from human synovial tissues using bulk transcriptomics of targeted subpopulations and single-cell transcriptomics. We identify seven fibroblast subsets with distinct surface protein phenotypes, and collapse them into three subsets by integrating transcriptomic data. One fibroblast subset, characterized by the expression of proteins podoplanin, THY1 membrane glycoprotein and cadherin-11, but lacking CD34, is threefold expanded in patients with RA relative to patients with osteoarthritis. These fibroblasts localize to the perivascular zone in inflamed synovium, secrete proinflammatory cytokines, are proliferative, and have an in vitro phenotype characteristic of invasive cells. Our strategy may be used as a template to identify pathogenic stromal cellular subsets in other complex diseases.

22 April 2020 in Nature
Verified
Journal Article
Closed access
PDF file
KWKevin Wei
Kevin Wei
IKIlya Korsunsky
Ilya Korsunsky
JMJennifer L. Marshall
Jennifer L. Marshall
AGAnqi Gao
Anqi Gao
GWGerald F. M. Watts
Gerald F. M. Watts
MBMichael B. Brenner
Michael B. Brenner

30 November 2012 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
CBChristopher D. Buckley
Christopher D. Buckley
DGDerek W. Gilroy
Derek W. Gilroy
CSCharles N. Serhan
Charles N. Serhan
BSBrigitta Stockinger
Brigitta Stockinger
PTPaul P. Tak
Paul P. Tak